{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T01:06:39Z","timestamp":1793581599963,"version":"4.5.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002661","name":"Fund for Scientific Research","doi-asserted-by":"publisher","award":["5\/4\/150\/5"],"award-info":[{"award-number":["5\/4\/150\/5"]}],"id":[{"id":"10.13039\/501100002661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.fertnstert.2025.07.030","type":"journal-article","created":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T23:35:36Z","timestamp":1753313736000},"page":"137-147","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Temsirolimus and antim\u00fcllerian hormone protect fertility and the ovarian reserve against chemotherapy-induced damage in a murine model"],"prefix":"10.1016","volume":"125","author":[{"given":"Lara","family":"Houeis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graziella","family":"van der Plancke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciana","family":"Cacciottola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Apolline","family":"Goudmaeker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Candice","family":"Kluyskens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margherita","family":"Zipponi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Paul","family":"Dehoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Donnez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6331-3026","authenticated-orcid":false,"given":"Marie-Madeleine","family":"Dolmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2025.07.030_bib1","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.fertnstert.2025.07.030_bib2","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1200\/JCO.2017.76.3441","article-title":"Reproductive function and outcomes in female survivors of childhood, adolescent, and young adult cancer: a review","volume":"36","author":"van Dorp","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.fertnstert.2025.07.030_bib3","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/0002-9343(71)90341-X","article-title":"Multiple late complications of therapy with cyclophosphamide, including ovarian destruction","volume":"50","author":"Miller","year":"1971","journal-title":"Am J Med"},{"key":"10.1016\/j.fertnstert.2025.07.030_bib4","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/humupd\/dmz027","article-title":"Ovarian damage from chemotherapy and current approaches to its protection","volume":"25","author":"Spears","year":"2019","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2025.07.030_bib5","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/0041-008X(91)90310-B","article-title":"Phosphoramide mustard is responsible for the ovarian toxicity of cyclophosphamide","volume":"107","author":"Plowchalk","year":"1991","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.fertnstert.2025.07.030_bib6","doi-asserted-by":"crossref","first-page":"3440","DOI":"10.1200\/JCO.2015.64.3288","volume":"34","author":"van Dorp","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.fertnstert.2025.07.030_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242216291","article-title":"Overactivation or apoptosis: which mechanisms affect chemotherapy-induced ovarian reserve depletion?","volume":"24","author":"Kashi","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.fertnstert.2025.07.030_bib8","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1097\/GRF.0b013e3181f96b54","article-title":"Toxicity of chemotherapy and radiation on female reproduction","volume":"53","author":"Meirow","year":"2010","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2025.07.030_bib9","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3005402","article-title":"Cyclophosphamide triggers follicle activation and \u201cburnout\u201d; AS101 prevents follicle loss and preserves fertility","volume":"5","author":"Kalich-Philosoph","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.fertnstert.2025.07.030_bib10","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1093\/humrep\/dem027","article-title":"Cortical fibrosis and blood-vessels damage in human ovaries exposed to chemotherapy. Potential mechanisms of ovarian injury","volume":"22","author":"Meirow","year":"2007","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2025.07.030_bib11","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1056\/NEJMra1614676","article-title":"Fertility preservation in women","volume":"377","author":"Donnez","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fertnstert.2025.07.030_bib12","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1093\/humrep\/den055","article-title":"Searching for evidence of disease and malignant cell contamination in ovarian tissue stored from hematologic cancer patients","volume":"23","author":"Meirow","year":"2008","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2025.07.030_bib13","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1182\/blood-2010-01-265751","article-title":"Reimplantation of cryopreserved ovarian tissue from patients with acute lymphoblastic leukemia is potentially unsafe","volume":"116","author":"Dolmans","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.fertnstert.2025.07.030_bib14","doi-asserted-by":"crossref","first-page":"4311","DOI":"10.1182\/blood-2012-01-403022","article-title":"Cryopreserved ovarian cortex from patients with leukemia in complete remission contains no apparent viable malignant cells","volume":"120","author":"Greve","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.fertnstert.2025.07.030_bib15","doi-asserted-by":"crossref","first-page":"4275","DOI":"10.1182\/blood-2012-07-439539","article-title":"Safety of ovarian autotransplantation","volume":"120","author":"Dolmans","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.fertnstert.2025.07.030_bib16","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1093\/humrep\/dead064","article-title":"Dual suppression of follicle activation pathways completely prevents the cyclophosphamide-induced loss of ovarian reserve","volume":"38","author":"Kashi","year":"2023","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2025.07.030_bib17","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1093\/humrep\/dead255","article-title":"Anti-Mullerian hormone attenuates both cyclophosphamide-induced damage and PI3K signalling activation, while rapamycin attenuates only PI3K signalling activation, in human ovarian cortex in vitro","volume":"39","author":"Rosario","year":"2024","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2025.07.030_bib18","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1096\/fj.201801089R","article-title":"AMH prevents primordial ovarian follicle loss and fertility alteration in cyclophosphamide-treated mice","volume":"33","author":"Sonigo","year":"2019","journal-title":"FASEB J"},{"key":"10.1016\/j.fertnstert.2025.07.030_bib19","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1007\/s10815-019-01507-9","article-title":"Pharmacological administration of recombinant human AMH rescues ovarian reserve and preserves fertility in a mouse model of chemotherapy, without interfering with anti-tumoural effects","volume":"36","author":"Roness","year":"2019","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.fertnstert.2025.07.030_bib20","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.1073\/pnas.1617233114","article-title":"mTORC1\/2 inhibition preserves ovarian function and fertility during genotoxic chemotherapy","volume":"114","author":"Goldman","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.fertnstert.2025.07.030_bib21","first-page":"177","article-title":"Chemotherapy-induced diminished murine ovarian reserve model and impact of low-dose chemotherapy on fertility","volume":"6","author":"Houeis","year":"2025","journal-title":"F S Sci"},{"issue":"Suppl B","key":"10.1016\/j.fertnstert.2025.07.030_bib22","doi-asserted-by":"crossref","first-page":"B101","DOI":"10.1016\/S0149-2918(00)89027-X","article-title":"Clinical pharmacokinetics and therapeutic drug monitoring of sirolimus","volume":"22","author":"MacDonald","year":"2000","journal-title":"Clin Ther"},{"key":"10.1016\/j.fertnstert.2025.07.030_bib23","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2165\/00003088-200443020-00002","article-title":"Clinical pharmacokinetics of everolimus","volume":"43","author":"Kirchner","year":"2004","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.fertnstert.2025.07.030_bib24","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jddst.2017.06.010","article-title":"Application of surfactants in solid dispersion technology for improving solubility of poorly water soluble drugs","volume":"41","author":"Chaudhari","year":"2017","journal-title":"J Drug Deliv Sci Technol"},{"key":"10.1016\/j.fertnstert.2025.07.030_bib25","doi-asserted-by":"crossref","first-page":"E1688","DOI":"10.1073\/pnas.1620729114","article-title":"AMH\/MIS as a contraceptive that protects the ovarian reserve during chemotherapy","volume":"114","author":"Kano","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.fertnstert.2025.07.030_bib26","doi-asserted-by":"crossref","first-page":"59","DOI":"10.20870\/productions-animales.2009.22.2.3335","article-title":"D\u00e9veloppement folliculaire ovarien et ovulation chez les mammif\u00e8res","volume":"22","author":"Monniaux","year":"2009","journal-title":"INRAE Prod Anim"},{"key":"10.1016\/j.fertnstert.2025.07.030_bib27","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3390\/genes2010152","article-title":"Meiosis in a bottle: new approaches to overcome Mammalian meiocyte study limitations","volume":"2","author":"Roig","year":"2011","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.fertnstert.2025.07.030_bib28","doi-asserted-by":"crossref","first-page":"95","DOI":"10.5653\/cerm.2012.39.3.95","article-title":"Regulation and 3 dimensional culture of tertiary follicle growth","volume":"39","author":"Cheon","year":"2012","journal-title":"Clin Exp Reprod Med"},{"key":"10.1016\/j.fertnstert.2025.07.030_bib29","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1093\/biolre\/ioz122","article-title":"Environmentally relevant exposure to dibutyl phthalate disrupts DNA damage repair gene expression in the mouse ovary\u2020","volume":"101","author":"Liu","year":"2019","journal-title":"Biol Reprod"},{"key":"10.1016\/j.fertnstert.2025.07.030_bib30","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.fertnstert.2022.09.360","article-title":"Follicle outcomes in human ovarian tissue: effect of freezing, culture, and grafting","volume":"119","author":"Hossay","year":"2023","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2025.07.030_bib31","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/j.fertnstert.2013.07.202","article-title":"Evaluation of cryopreserved ovarian tissue from prepubertal patients after long-term xenografting and exogenous stimulation","volume":"100","author":"Luyckx","year":"2013","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2025.07.030_bib32","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/humrep\/dey355","article-title":"Long-term follow-up of vitrified and autografted baboon (Papio anubis) ovarian tissue","volume":"34","author":"Amorim","year":"2019","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2025.07.030_bib34","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1538\/expanim.18-0042","article-title":"Protective effect of a mechanistic target of rapamycin inhibitor on an in vivo model ofcisplatin-induced ovarian gonadotoxicity","volume":"67","author":"Tanaka","year":"2018","journal-title":"Exp Anim"},{"key":"10.1016\/j.fertnstert.2025.07.030_bib37","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1093\/humrep\/deae085","article-title":"Rapamycin prevents cyclophosphamide-induced ovarian follicular loss and potentially inhibits tumour proliferation in a breast cancer xenograft mouse model","volume":"39","author":"Tanaka","year":"2024","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2025.07.030_bib33","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/hmg\/ddp483","article-title":"Tsc\/mTORC1 signaling in oocytes governs the quiescence and activation of primordial follicles","volume":"19","author":"Adhikari","year":"2010","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.fertnstert.2025.07.030_bib35","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.cell.2007.06.009","article-title":"AKT\/PKB signaling: navigating downstream","volume":"129","author":"Manning","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.fertnstert.2025.07.030_bib36","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s11523-011-0174-9","article-title":"Common toxicities of mammalian target of rapamycin inhibitors","volume":"6","author":"Soefje","year":"2011","journal-title":"Target Oncol"},{"key":"10.1016\/j.fertnstert.2025.07.030_bib38","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1186\/s12935-022-02706-8","article-title":"Recent advances and limitations of mTOR inhibitors in the treatment of cancer","volume":"22","author":"Ali","year":"2022","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.fertnstert.2025.07.030_bib39","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.ctrv.2012.12.012","article-title":"Oral and intravenously administered mTOR inhibitors for metastatic renal cell carcinoma: pharmacokinetic considerations and clinical implications","volume":"39","author":"Danesi","year":"2013","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.fertnstert.2025.07.030_bib40","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1210\/endo.143.3.8691","article-title":"Anti-M\u00fcllerian hormone inhibits initiation of primordial follicle growth in the mouse ovary","volume":"143","author":"Durlinger","year":"2002","journal-title":"Endocrinology"},{"key":"10.1016\/j.fertnstert.2025.07.030_bib41","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1093\/humrep\/del165","article-title":"Anti-M\u00fcllerian hormone inhibits initiation of growth of human primordial ovarian follicles in vitro","volume":"21","author":"Carlsson","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2025.07.030_bib42","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s10815-019-01622-7","article-title":"The role of anti-M\u00fcllerian hormone (AMH) in ovarian disease and infertility","volume":"37","author":"Bedenk","year":"2020","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.fertnstert.2025.07.030_bib43","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1093\/humrep\/16.4.632","article-title":"Administration of cyclophosphamide at different stages of follicular maturation in mice: effects on reproductive performance and fetal malformations","volume":"16","author":"Meirow","year":"2001","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2025.07.030_bib44","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1530\/JOE-18-0370","article-title":"Inhibitors of apoptosis protect the ovarian reserve from cyclophosphamide","volume":"240","author":"Luan","year":"2019","journal-title":"J Endocrinol"},{"key":"10.1016\/j.fertnstert.2025.07.030_bib45","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1002\/cncr.23071","article-title":"Quantitative assessment of the impact of chemotherapy on ovarian follicle reserve and stromal function","volume":"110","author":"Oktem","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.fertnstert.2025.07.030_bib46","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/s41598-020-79643-x","article-title":"Individual-oocyte transcriptomic analysis shows that genotoxic chemotherapy depletes human primordial follicle reserve in vivo by triggering proapoptotic pathways without growth activation","volume":"11","author":"Titus","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.fertnstert.2025.07.030_bib47","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s13048-017-0339-y","article-title":"Ovarian preservation in adenocarcinoma of the uterine cervix","volume":"10","author":"Zhou","year":"2017","journal-title":"J Ovarian Res"},{"key":"10.1016\/j.fertnstert.2025.07.030_bib48","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.fertnstert.2020.11.040","article-title":"Ovaries of patients recently treated with alkylating agent chemotherapy indicate the presence of acute follicle activation, elucidating its role among other proposed mechanisms of follicle loss","volume":"115","author":"Shai","year":"2021","journal-title":"Fertil Steril"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001502822500603X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001502822500603X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T16:16:56Z","timestamp":1772813816000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001502822500603X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S001502822500603X"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2025.07.030","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Temsirolimus and antim\u00fcllerian hormone protect fertility and the ovarian reserve against chemotherapy-induced damage in a murine model","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2025.07.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a92025 American Society for Reproductive Medicine, Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}